Press Releases

GlobeNewswire, Inc.

Marks a major milestone in Nasdaq Calypso’s strategy to serve as the trusted orchestration layer connecting agents across capital market and treasury workflows Introduces agentic capabilities, including a natural language assistant to automate...

GlobeNewswire, Inc.

Powerus and Aureus Greenway Holdings completed their previously announced merger, effective October 1, 2026. AGH has been renamed Powerus Corporation, and continues to operate as a public company.

GlobeNewswire, Inc.

KING OF PRUSSIA, Pa., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), the Decision-to-Defense™ global indirect tax and compliance company, today announced the appointment of Debanjan Saha to its Board of...

GlobeNewswire, Inc.

LONDON, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Team CATALYST, a multinational team led by By Light Professional IT Services LLC, will continue to Sprint 3 of NATO Allied Command Transformation’s Agile Procurement Process for the Next Generation...

Pennsylvania General Assembly

PENNSYLVANIA, September 30 - House of Representatives Daily Session Update Prepared by the Office of the Parliamentarian September 30, 2026 Convened at 11 A.M. Adjourned at 4:20 P.M. Opening Prayer by Representative Barton.

GlobeNewswire, Inc.

PARIS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Pasqal (NASDAQ: PSQL), a global leader in neutral-atom quantum computing, today announced the appointment of Florence Lao as Chief Legal Officer.

GlobeNewswire, Inc.

330 patients randomized as of September 30, 2026, surpassing full trial enrollment target Company reiterates prior guidance: primary endpoint data to be submitted for late-breaking presentation consideration at a major cardiovascular conference in...

GlobeNewswire, Inc.

SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have...

GlobeNewswire, Inc.

Analysis of 3,918 adults across Germany, the Netherlands and France, with no eligibility criteria beyond active system use, covering 323,814 person-days of real-world experience Users achieved median time in range of 72.2%, while median time below...

GlobeNewswire, Inc.

Jena, Germany, Oct. 01, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced the appointment of Gabriela Alperovich, MD,...

GlobeNewswire, Inc.

SpyGlass Pharma acquires 100% of the outstanding shares of AVS, a subsidiary of Santen Pharmaceutical Co., Ltd. (Santen), the existing manufacturer of SpyGlass Pharma’s intraocular lens (IOL) Secures scalable commercial IOL manufacturing capacity...

GlobeNewswire, Inc.

DALLAS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic...

GlobeNewswire, Inc.

Interim analysis results from clinical study evaluating tafenoquine in severe babesiosis (NCT06207370) to be disclosed on October 6, 2026. Key Opinion Leader investor webinar scheduled for October 6, 2026, featuring leading babesiosis experts Dr....

GlobeNewswire, Inc.

Following meeting with FDA, Wave plans for a single, two-year registrational trial, with a one-year interim analysis for potential accelerated approval based on AATD biomarkers WVE-006 (RNA editing) has potential to offer the AATD community a new...

GlobeNewswire, Inc.

In obese subjects at elevated cardiovascular disease (CVD) risk, MRT-8102, a NEK7-directed molecular glue degrader in development for the treatment of NLRP3/IL-1-driven inflammatory diseases, normalized multiple atherosclerotic cardiovascular...

GlobeNewswire, Inc.

Leader in Global Drug Development of T Cell Therapies PHILADELPHIA, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel...

GlobeNewswire, Inc.

LOS ANGELES, Sept. 29, 2026 (GLOBE NEWSWIRE) -- WANPY® Chicken Jerky was named “Jerky-Style Dog Treat of the Year” in the 2026 Pet Innovation Awards, underscoring a major shift in the dog treat category as premiumization moves beyond marketing...

GlobeNewswire, Inc.

– RECEPTIVE-HS1 Phase 2 clinical trial in patients with moderate to severe hidradenitis suppurativa (HS) expected to initiate in 2026; data from the 16-week treatment period expected in the first half of 2028 – – HS is the second Phase 2...

GlobeNewswire, Inc.

WARMINSTER, Pa., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today announced the final results of its tender...

GlobeNewswire, Inc.

SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Beam Global (Nasdaq: BEEM), a leading provider of innovative and sustainable infrastructure solutions for energy storage and security, electrification of mobility, and smart city infrastructure, today...